Idiopathic CD4+ T lymphocytopenia disclosed by the onset of empyema thoracis. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Idiopathic CD4+ T lymphocytopenia disclosed by the onset of empyema thoracis.

Intern Med. 1999 Jan;38(1):40-4. Unique Identifier : AIDSLINE MED/99160106
Hamanishi T; Nakao T; Nishino M; Yanagawa T; Kobayashi M; Sasaki H; Matsumoto G; Sanke T; Nanjyo K; First Department of Medicine, Wakayama University of Medical; Science.


Abstract: A 56-year-old man was admitted to our hospital in December 1996 due to empyema thoracis. A laboratory examination revealed lymphocytopenia and CD4+ T lymphocytopenia (<300 cells/ microl). No evidence for a human immunodeficiency virus (HIV) infection was found. No malignant, hematological or autoimmune disease was detected. We thus diagnosed this case as being idiopathic CD4+ T lymphocytopenia (ICL). During his hospital treatment, he was affected with cytomegaloviral retinitis and cured by therapy. His subsequent treatment went well without a recurrence of severe infection although a low CD4+ T lymphocyte count continued after the recovery from empyema thoracis.
Keywords: JOURNAL ARTICLE Antibiotics, Combined/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Antiviral Agents/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Case Report Cytomegalovirus Retinitis/DIAGNOSIS/DRUG THERAPY/ETIOLOGY CD4 Lymphocyte Count Diagnosis, Differential Drug Therapy, Combination Empyema, Pleural/DIAGNOSIS/*ETIOLOGY/THERAPY Follow-Up Studies Ganciclovir/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Human Immunosuppressive Agents/THERAPEUTIC USE Injections, Intravenous Male Middle Age Retrospective Studies Suction T-Lymphocytopenia, Idiopathic CD4-Positive/*COMPLICATIONS/ DIAGNOSIS/DRUG THERAPY
990730
A9971202

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .